Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria

• Główni autorzy: Katelyn E. Madigan (Autor), Sean R. Rudnick (Autor), Matthew A. Agnew (Autor), Numra Urooj (Autor), Herbert L. Bonkovsky (Autor)
• Format: Książka
• Wydane: MDPI AG, 2023-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Erythropoietic protoporphyria (EPP) is a genetic disorder stemming from reduced ferrochelatase expression, the final enzyme in the pathway of heme biosynthesis. A closely related condition, X-linked protoporphyria (XLP), bears similar clinical features although it arises from the heightened activity...